Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.

Safety and antigenicity of a purified preparation of Salmonella typhosa Vi antigen was evaluated in human volunteers. Dosages of Vi antigen at 25, 50, and 100 mug were less toxic than U.S. standard typhoid vaccine (lot 6A) containing 5 X 10(8) bacteria per dosage. Vi antigen in comparison with the s...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Infect Immun
Egile Nagusiak:	Levin, D M, Wong, K H, Reynolds, H Y, Sutton, A, Northrup, R S
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1975
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC415434/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/54336/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.12.6.1290-1294.1975
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!